Comerica Bank Exact Sciences Corp Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, Comerica Bank holds 3,257 shares of EXAS stock, worth $172,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,257

Previous 7,099 54.12%

Holding current value

$172,327

Previous $299,000 26.09%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$42.43 - $70.83 $163,016 - $272,128	-3,842 Reduced 54.12%	3,257 $221,000
Q2 2024 Aug 15, 2024	SELL	$41.33 - $74.26 $421,896 - $758,046	-10,208 Reduced 58.98%	7,099 $299,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $570,015 - $747,290	10,130 Added 141.15%	17,307 $1.2 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $8,563 - $10,979	-145 Reduced 1.98%	7,177 $530,000
Q3 2023 Nov 21, 2023	SELL	$65.94 - $99.04 $893,223 - $1.34 Million	-13,546 Reduced 64.91%	7,322 $499,000
Q2 2023 Aug 22, 2023	BUY	$62.68 - $95.05 $1.31 Million - $1.98 Million	20,868 New	20,868 $57,000
Q3 2021 Nov 22, 2021	SELL	$90.24 - $124.05 $456,794 - $627,941	-5,062 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$93.66 - $139.27 $15,172 - $22,561	162 Added 3.31%	5,062 $629,000
Q1 2021 Apr 28, 2021	SELL	$116.57 - $155.01 $65,162 - $86,650	-559 Reduced 10.24%	4,900 $645,000
Q4 2020 Jan 28, 2021	SELL	$99.61 - $142.12 $35,560 - $50,736	-357 Reduced 6.14%	5,459 $723,000
Q3 2020 Oct 30, 2020	SELL	$72.92 - $102.01 $9,479 - $13,261	-130 Reduced 2.19%	5,816 $592,000
Q2 2020 Jul 31, 2020	BUY	$55.75 - $92.75 $32,056 - $53,331	575 Added 10.71%	5,946 $516,000
Q1 2020 May 01, 2020	BUY	$37.9 - $104.44 $4,623 - $12,741	122 Added 2.32%	5,371 $311,000
Q4 2019 Feb 07, 2020	SELL	$77.66 - $99.74 $295,263 - $379,211	-3,802 Reduced 42.01%	5,249 $485,000
Q3 2019 Oct 31, 2019	SELL	$90.37 - $122.49 $441,728 - $598,731	-4,888 Reduced 35.07%	9,051 $817,000
Q2 2019 Aug 02, 2019	BUY	$89.51 - $118.04 $882,658 - $1.16 Million	9,861 Added 241.81%	13,939 $0
Q1 2019 May 02, 2019	BUY	$61.98 - $96.5 $4,214 - $6,562	68 Added 1.7%	4,078 $0
Q4 2018 Feb 06, 2019	SELL	$56.04 - $82.66 $19,501 - $28,765	-348 Reduced 7.99%	4,010 $343,000
Q3 2018 Nov 01, 2018	SELL	$48.29 - $80.6 $1,158 - $1,934	-24 Reduced 0.55%	4,358 $275,000
Q2 2018 Aug 01, 2018	BUY	$37.84 - $69.96 $165,814 - $306,564	4,382 New	4,382 $292,000
Q1 2018 May 01, 2018	SELL	$39.82 - $57.53 $166,766 - $240,935	-4,188 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$46.49 - $60.51 $27,103 - $35,277	-583 Reduced 12.22%	4,188 $216,000
Q3 2017 Nov 06, 2017	BUY	$37.05 - $47.12 $176,765 - $224,809	4,771	4,771 $239,000

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account